In the context of ALF, it was demonstrated that intraperitoneal administration of an antibody neutralizing the TGF-β1 improves the neurological status and increased the expression of Gli1, a protein showing neuroprotection in the HE [24]; however, the exact mechanism was not proposed. The gene discussed is GLI1; the disease is hereditary elliptocytosis.